Just to reiterate for a non-medically trained indi
Post# of 148293
1. Stop the trial due to dangerous side effects or no efficacy. This is highly unlikely based on anecdotal evidence, safety and M/M results
2. Looks good so far. Keep going until full enrollment. Payday comes later.
3. LL hits it out of the park. Trial stopped. LL administered to placebo patients for ethical reasons. The eagle flies high.
Scenarios 2 or 3 are likely. Based on the SCIENCE we are all gonna get paid. The BIG question comes down to politics and BP’s $$ and influence.
I feel as if I’m at the roulette table. I just don’t know if I’ve bet on the black, or 32 black.